GAF Healthcare
Specialty Overview

Best Hospitals for Salivary Gland Cancer Treatment in Chennai, India

8 medical oncology hospitals in our India network are listed in Chennai, accredited by JCI, NABH, NABL, with 4,035 beds combined.

8
Hospitals Listed
1
City
4.5
Avg. Rating
3
Accreditation Types
The Short Answer

This page lists the medical oncology hospitals in our directory offering Salivary Gland Cancer Treatment in Chennai, India, including Apollo Hospitals, Greams Road, Gleneagles Global Hospital, Dr. Rela Institute and Medical Centre, SIMS Hospital and others. Each listing links through to the hospital's full profile page.

Including:🇮🇳 Apollo Hospitals, Greams Road🇮🇳 Gleneagles Global Hospital🇮🇳 Dr. Rela Institute and Medical Centre

Ask us about salivary gland cancer treatment in Chennai, India

Share a few details and our care coordination team will get back to you with next steps.

Compare 8 accredited hospitals for Medical Oncology in Chennai, India

Apollo Hospitals, Greams Road Featured
Starting from$1,000

🇮🇳 Apollo Hospitals, Greams Road

Chennai, India 4.7 (125 reviews) 560 beds
Why consider this hospital?
4.7/5 rating from 125 reviewsAccredited by JCI, NABH560 bedsHas a dedicated Medical Oncology department
Specialties & Accreditation
Medical OncologyCardiac SurgeryCardiologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering salivary gland cancer treatment can be cared for by Apollo Hospitals, Greams Road's Medical Oncology department in Chennai, India, from initial consultation through recovery. Apollo Hospitals, Greams Road, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing salivary gland cancer treatment.

4.7/5
Rating
1983
Established
560
Beds
Chennai, India
Location
Enquire NowView Profile
Gleneagles Global Hospital
Starting from$1,000

🇮🇳 Gleneagles Global Hospital

Chennai, India 4.7 (112 reviews) 1,000 beds
Why consider this hospital?
4.7/5 rating from 112 reviewsAccredited by NABH, JCI1,000 bedsHas a dedicated Medical Oncology department
Specialties & Accreditation
Medical OncologyCardiac SurgeryCardiologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by NABH, JCI

Patients considering salivary gland cancer treatment can be cared for by Gleneagles Global Hospital's Medical Oncology department in Chennai, India, from initial consultation through recovery. Gleneagles Global Hospital, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing salivary gland cancer treatment.

4.7/5
Rating
1999
Established
1,000
Beds
Chennai, India
Location
Enquire NowView Profile
Dr. Rela Institute and Medical Centre
Starting from$1,000

🇮🇳 Dr. Rela Institute and Medical Centre

Chennai, India 4.7 (108 reviews) 450 beds
Why consider this hospital?
4.7/5 rating from 108 reviewsAccredited by NABH, NABL450 bedsHas a dedicated Medical Oncology department
Specialties & Accreditation
Medical OncologyCardiac SurgeryCardiologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by NABH, NABL

Patients considering salivary gland cancer treatment can be cared for by Dr. Rela Institute and Medical Centre's Medical Oncology department in Chennai, India, from initial consultation through recovery. Dr. Rela Institute and Medical Centre, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing salivary gland cancer treatment.

4.7/5
Rating
2018
Established
450
Beds
Chennai, India
Location
Enquire NowView Profile
SIMS Hospital
Starting from$1,000

🇮🇳 SIMS Hospital

Chennai, India 4.6 (20 reviews) 345 beds
Why consider this hospital?
4.6/5 rating from 20 reviewsAccredited by NABH, JCI345 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesTransplantOrthopedicsGastroenterology
Accredited by NABH, JCI

Patients considering salivary gland cancer treatment can be cared for by SIMS Hospital's care team in Chennai, India, from initial consultation through recovery. SIMS Hospital, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing salivary gland cancer treatment.

4.6/5
Rating
1970
Established
345
Beds
Chennai, India
Location
Enquire NowView Profile
Sankara Nethralaya
Starting from$1,000

🇮🇳 Sankara Nethralaya

Nungambakkam, Chennai, India 4.4 (220 reviews) 200 beds
Why consider this hospital?
4.4/5 rating from 220 reviewsAccredited by NABH, NABL200 beds
Specialties & Accreditation
OphthalmologyRetina SurgeryCornea TransplantGlaucomaPediatric Ophthalmology
Accredited by NABH, NABL

Patients considering salivary gland cancer treatment can be cared for by Sankara Nethralaya's care team in Nungambakkam, Chennai, India, from initial consultation through recovery. Sankara Nethralaya, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing salivary gland cancer treatment.

4.4/5
Rating
1978
Established
200
Beds
Nungambakkam, Chennai, India
Location
Enquire NowView Profile
Apollo First Med Hospitals, Kilpauk
Starting from$1,000

🇮🇳 Apollo First Med Hospitals, Kilpauk

Kilpauk, Chennai, India 4.4 (76 reviews) 80 beds
Why consider this hospital?
4.4/5 rating from 76 reviewsAccredited by NABH, JCI80 beds
Specialties & Accreditation
Cardiac SciencesOrthopedicsNeurologyOncologyGastroenterology
Accredited by NABH, JCI

Patients considering salivary gland cancer treatment can be cared for by Apollo First Med Hospitals, Kilpauk's care team in Kilpauk, Chennai, India, from initial consultation through recovery. Apollo First Med Hospitals, Kilpauk, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing salivary gland cancer treatment.

4.4/5
Rating
2002
Established
80
Beds
Kilpauk, Chennai, India
Location
Enquire NowView Profile
MIOT International
Starting from$1,000

🇮🇳 MIOT International

Manapakkam, Chennai, India 4.4 (200 reviews) 1,000 beds
Why consider this hospital?
4.4/5 rating from 200 reviewsAccredited by NABH, NABL, JCI1,000 beds
Specialties & Accreditation
OrthopedicsCardiac SurgeryNeurosciencesTransplantOncology
Accredited by NABH, NABL, JCI

Patients considering salivary gland cancer treatment can be cared for by MIOT International's care team in Manapakkam, Chennai, India, from initial consultation through recovery. MIOT International, accredited by NABH, NABL, JCI, follows recognised patient-safety and quality-of-care standards when performing salivary gland cancer treatment.

4.4/5
Rating
1999
Established
1,000
Beds
Manapakkam, Chennai, India
Location
Enquire NowView Profile
MGM Healthcare
Starting from$1,000

🇮🇳 MGM Healthcare

Chennai, India 3.7 (34 reviews) 400 beds
Why consider this hospital?
3.7/5 rating from 34 reviewsAccredited by NABH, JCI400 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesTransplantCancer CareOrthopedics
Accredited by NABH, JCI

Patients considering salivary gland cancer treatment can be cared for by MGM Healthcare's care team in Chennai, India, from initial consultation through recovery. MGM Healthcare, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing salivary gland cancer treatment.

3.7/5
Rating
1970
Established
400
Beds
Chennai, India
Location
Enquire NowView Profile
Our Methodology

How we selected these hospitals

A hospital appears on this page when Medical Oncology is among its listed specialties and it is located in Chennai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Salivary Gland Cancer Treatment in Chennai, India?

Choosing the right hospital for salivary gland cancer treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include medical oncology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Salivary Gland Cancer Treatment

Salivary gland cancer is a rare but complex malignancy requiring subspecialty surgical oncology, advanced radiation techniques, and increasingly, molecularly targeted systemic therapy.

5–10 days (varies by extent of resection and neck dissection requirement)
Hospital Stay
4–8 weeks (wound healing, post-operative radiotherapy planning, and swallowing rehabilitation must be stable before long-haul flight)
Total Stay in Country (Fit-to-Fly)
78–92% (stage-dependent five-year overall survival; highest for low-grade, organ-confined disease)
Success Rate

Clinical Overview

  • Salivary gland cancers are a heterogeneous group of epithelial malignancies arising in the parotid (70–80% of cases), submandibular, sublingual, or minor salivary glands distributed throughout the oral cavity, oropharynx, and sinonasal tract.
  • The WHO Classification of Head and Neck Tumours (2022) recognises more than 20 distinct histological subtypes — including mucoepidermoid carcinoma (the most common), adenoid cystic carcinoma (notable for perineural invasion and late distant metastasis), acinic cell carcinoma, secretory carcinoma (characterised by ETV6-NTRK3 fusion), salivary duct carcinoma, and carcinoma ex pleomorphic adenoma.
  • Tumour grade (low, intermediate, high) is the single strongest predictor of behaviour: low-grade lesions are frequently cured with surgery alone, whereas high-grade tumours carry a significant risk of regional nodal spread, distant metastasis to lung, bone, or liver, and require multimodal therapy.
Full details →

Who is a Candidate?

  • Newly diagnosed or recurrent primary salivary gland malignancy confirmed by core-needle or incisional biopsy with histopathological review
  • Resectable disease (T1–T4a) in the parotid, submandibular, sublingual, or minor salivary glands where curative intent surgery is feasible
  • Patients with high-grade histology (salivary duct carcinoma, carcinoma ex pleomorphic adenoma, high-grade mucoepidermoid) who require adjuvant IMRT ± systemic therapy
  • Patients with locally advanced or recurrent disease being evaluated for re-irradiation, palliative surgery, or systemic therapy
  • +2 more

Required Diagnostic Workup Before Travel:

Full details →

Treatment Options & Approaches

  • SURGICAL APPROACHES

Recovery

  • PHASE 1 — REMOTE CONSULTATION AND PRE-TRAVEL PREPARATION (Weeks 1–2)

Risks to be aware of

  • Salivary gland cancer surgery and multimodal treatment carry a defined spectrum of risks that patients must understand before committing to a treatment plan.
  • The most consequential surgical risk is facial nerve injury during parotidectomy: temporary neuropraxia (weakness without axonal disruption) occurs in 15–30% of cases and usually resolves within 3–6 months; permanent palsy due to deliberate nerve sacrifice for oncological clearance occurs in 5–15% of radical resections and necessitates facial reanimation procedures.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides an end-to-end concierge infrastructure designed specifically for international oncology patients, ensuring that non-medical barriers never delay timely cancer treatment.

Cost Range for Related Procedures

Cancer Surgery$4,000–$15,000
Chemotherapy$1,000–$4,000
Radiation Therapy$3,500–$10,000
Get a personalised estimate with our cost calculator →

Common questions about Salivary Gland Cancer Treatment

What is the cost of Salivary Gland Cancer Treatment in India compared to the UAE?
The total cost of salivary gland cancer treatment in India ranges from approximately USD 4,500 to USD 18,000, depending on the extent of surgery (superficial parotidectomy versus total parotidectomy with free-flap reconstruction and neck dissection), the requirement for adjuvant IMRT radiotherapy (typically an additional USD 2,500–6,000 for 30 fractions), and whether targeted systemic therapy such as trastuzumab or larotrectinib is included. In the UAE (Dubai and Abu Dhabi), equivalent treatment costs between USD 9,000 and USD 35,000 for the surgical episode, reflecting higher facility fees, premium private-room standards, and JCI/DHA-accredited infrastructure. India is therefore 40–60% less expensive for comparable oncological expertise and outcomes, and all costs are transparent with GAF Healthcare's itemised pre-treatment estimate. Both destinations offer internationally accredited centres with fellowship-trained head-and-neck surgical oncologists, intraoperative facial nerve monitoring, robotic-assisted surgery (TORS), and state-of-the-art IMRT radiation planning — the choice depends largely on the patient's proximity, budget, and preferences regarding language and environment.
How long do I need to stay in the country before I am fit to fly home after Salivary Gland Cancer Treatment?
The minimum required stay before international air travel depends on the treatment received. For patients who underwent surgical resection alone (without adjuvant radiotherapy), fit-to-fly status is typically confirmed at 4–6 weeks post-operatively, once the surgical wound is fully healed with no active fistula or sialocele, post-operative baseline MRI has been completed, swallowing is adequate to safely maintain hydration during a long-haul flight, and the surgical oncologist has issued formal flight clearance. For patients who require adjuvant IMRT radiotherapy (a 6-week, 30-fraction course beginning 4–6 weeks after surgery), the total in-country stay extends to 8–12 weeks, with fitness to fly assessed 1–2 weeks after radiation completion. Patients commencing systemic targeted therapy (e.g., trastuzumab, larotrectinib) can typically fly after 1–2 treatment cycles (3–6 weeks) if toxicity is manageable and a treatment continuation plan with their home oncologist is confirmed. GAF Healthcare's case coordinators track each milestone and arrange fit-to-fly documentation, a comprehensive discharge summary, and all imaging files and dosimetry records for seamless handover to the patient's home cancer centre.
What is the success rate of Salivary Gland Cancer Treatment?
Success rates for salivary gland cancer treatment are strongly stage- and histology-dependent, making a single figure misleading without clinical context. For low-grade, organ-confined tumours (Stage I–II) — such as low-grade mucoepidermoid carcinoma or acinic cell carcinoma — treated with complete surgical excision, five-year overall survival exceeds 90–95% and local recurrence rates are below 5%. For intermediate-grade tumours managed with surgery plus adjuvant IMRT, five-year survival is 75–85%. For high-grade malignancies — including high-grade mucoepidermoid carcinoma, salivary duct carcinoma, and carcinoma ex pleomorphic adenoma — five-year survival ranges from 50–70% with multimodal therapy. Adenoid cystic carcinoma is notable for a favourable early five-year survival (70–80%) but a persistent 15–20 year late relapse rate due to distant metastasis, requiring lifelong surveillance. The advent of biomarker-driven targeted therapy has meaningfully improved outcomes in the metastatic setting: HER2-directed regimens achieve objective response rates of 50–70% in HER2-amplified salivary duct carcinoma, and NTRK inhibitors produce durable responses exceeding 75% in ETV6-NTRK3 fusion-positive secretory carcinoma. At GAF Healthcare's partner centres, oncological outcomes are benchmarked against international quality registries, with R0 (margin-negative) resection rates above 85% and complication rates consistent with published data from leading Western academic cancer centres.

Related pages

How GAF Healthcare Assists in Choosing the Best Hospital for Salivary Gland Cancer Treatment in Chennai, India

Discover the Top Hospitals for Salivary Gland Cancer Treatment in Chennai, India

This page lists 8 accredited medical oncology hospitals in Chennai, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about salivary gland cancer treatment in Chennai, India

How many medical oncology hospitals are listed in Chennai, India?
8 hospitals in our Chennai, India directory are currently listed for medical oncology including Salivary Gland Cancer Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Medical Oncology is among its listed specialties and it is located in Chennai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there medical oncology hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, NABL — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for salivary gland cancer treatment?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about salivary gland cancer treatment in Chennai, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for salivary gland cancer treatment in Chennai, India.

Contact us to report an inaccuracy on this page.

WhatsApp Us